Albertsons Companies Inc.

NYSE: ACI
$21.37
-$0.08 (-0.4%)
Closing price February 7, 2023
U.S. markets closed mixed on Tuesday and traded slightly higher Wednesday morning, ahead of reports on the producer price index and retail sales.
Albertsons and Bed Bath & Beyond are set to report quarterly results before markets open on Tuesday.
Here is a look at several stocks making big moves in early premarket action Friday.
Thursday's top analyst upgrades and downgrades included Albertsons Companies, Ally Financial, Datadog, Dominion Energy, Oracle, Southern, Spotify Technology, Sunnova Energy, Sunrun and Xcel Energy.
Monday’s additional top analyst upgrades and downgrades were on Albertsons Companies, Apple, Clorox, Cloudflare, Fox, Kroger, Opendoor Technologies, Petroleo Brasileiro and more.
Here is a preview of what to expect when these four firms report quarterly results before markets open on Tuesday.
Kroger has reached an agreement to merge with competitor Albertsons in a deal that values the Boise-based company at around $24.6 billion.
These four stocks are among those reporting quarterly results before markets open on Tuesday.
Thursday's top analyst upgrades and downgrades included Albertsons, Amazon.com, CarMax, Carnival, Chipotle Mexican Grill, Delta Air Lines, eBay, Etsy, GameStop, IBM, Meta Platforms, Nvidia and...
Here are previews of what to expect when three companies release quarterly earnings on Tuesday morning.
Wednesday afternoon's top analyst upgrades and downgrades included AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and more.
Monday's top analyst upgrades and downgrades included Airbnb, AT&T, Duke Energy, Etsy, FirstEnergy, Gap, IBM, KeyCorp, Kohl's, Las Vegas Sands, Nvidia, Starbucks, Trade Desk and Visa.
Here are three previews for companies reporting either Monday or Tuesday morning of next week.
Wednesday’s early top analyst upgrades and downgrades included Albertsons, AppLovin, Array Technologies, eBay, Freeport-McMoRan, GameStop, Melco Resorts, Navitas Semiconductor, Nike and Novartis.
These five stay-at-home and pharmaceutical stocks perhaps make sense now, on concerns over the Omicron variant of COVID-19. They are Buy rated and pay solid dividends, and they may be solid ideas as...